Ontada®, a McKesson business dedicated to transforming community oncology through technology, data and insights, today announced that new artificial intelligence capabilities are now available to all iKnowMed® customers, including practices in The US Oncology Network and independent practices across the country. Designed to help oncology practices improve productivity, streamline everyday workflows and reduce administrative burden, the new capabilities also advance Ontada’s broader Intelligent Medical Record strategy to bring greater intelligence into the technology providers and care teams already use.

The new offering brings several connected AI capabilities together in one platform: ambient documentation that helps draft visit notes, summaries designed to make it easier to review patient charts and visits, smart coding that suggests appropriate diagnosis codes based on visit context, a Practice Assistant that supports provider and practice questions, clinical decision-making and workflow guidance, and dictation that converts spoken words into text wherever the cursor is placed. Bringing these capabilities together provides practices with a more unified experience rather than requiring providers and care teams to rely on separate tools for individual tasks.

“We believe AI can deliver greater value when it is connected to the technology and workflows oncology practices already use, rather than operating as another standalone solution,” said Rob Helton, chief product officer, Ontada. “By unifying these capabilities into iKnowMed workflows clinicians use every day, practices can immediately benefit while creating the foundation for a much broader Intelligent Medical Record, one that helps clinicians work more efficiently, helps practices operate more effectively and continually becomes smarter as new capabilities are added.”

Ontada developed these capabilities in collaboration with Commure, a healthcare company that delivers AI application solutions to electronic health record platforms and providers. Unlike standalone AI tools focused on a single task, iKnowMed brings documentation, summarization, coding, practice assistance and dictation into a single workflow within a broader technology platform for oncology practices.

The launch follows real-world use by early adopters at select community oncology practices. Their input helped shape how the technology comes to life within iKnowMed, reflecting the needs and workflows of oncology providers and care teams. This collaboration brings together Commure’s broader healthcare AI capabilities with Ontada’s deep understanding of community oncology and the practices it serves.

“These new capabilities are exciting because they can help address real clinical pain points, including preparing for visits, documenting care and reducing routine follow-up work,” said Brian Heller, MD, president, Southern Cancer Center. “Just as important, this opens the door for what is possible next: a more integrated experience that continues to improve how physicians, care teams and practices work together on behalf of patients.”

The offering is part of Ontada’s broader Intelligent Medical Record strategy to evolve iKnowMed beyond a traditional system of record into a system of intelligence and action. Over time, Ontada plans to bring AI, data, clinical workflows and connected partner solutions into a more unified oncology experience, helping practices simplify their technology environment and expanding the value iKnowMed delivers over time.

About Ontada®

Ontada is an oncology technology and insights business dedicated to transforming the fight against cancer. Part of McKesson Corporation, Ontada was founded on the belief that precise insights—delivered exactly at the point of need—can save more patients’ lives. Ontada connects the full patient journey by combining technologies used by The US Oncology Network and other community oncology providers with real-world data and research relied on by leading life sciences companies. For more information, visit ontada.com.

About McKesson Oncology & Multispecialty

Our Oncology & Multispecialty segment delivers a portfolio of integrated solutions that support patient care by accelerating drug development, expanding access to high-quality care close to home and ensuring life-saving therapies reach the patients who need them most. We provide practice management, technology solutions, specialty drug distribution, clinical trial and group purchasing services, along with pharmacy solutions for community-based oncology practices and multispecialty providers in retina and ophthalmology. We partner behind the scenes with healthcare providers in local communities, supporting their operations so that they can stay focused on who matters most – patients.

Media gallery

About The Author
Business Wire